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Cells selected for overexpression of the integrin a5131 show decreased proliferation and
loss of the transformed phenotype. We provide evidence that de novo expression of the
integrin ca5,31 in HT29 colon carcinoma cells results in the growth arrest of these cells as
characterized by reduced DNA synthesis and cellular proliferation in vitro. In fact,
expression of integrin a5f31 on these cells induces the transcription of growth arrest
specific gene 1 (gas-i), a gene product known to induce cellular quiescence, but blocks
transcription of the immediate early genes c-fos, c-jun, and jun B. In vivo, the a5/31
transfectants display dramatically reduced tumorigenicity as well as a highly differenti-
ated phenotype when compared with their pSVneo-transfected counterparts. Surpris-
ingly, ligation of a5f31 on these cells by cell attachment to a fibronectin substrate not only
reverses the growth inhibition and gas-i gene induction but activates immediate early
gene transcription. These findings demonstrate that integrin a5131 expression in the
absence of attachment to fibronectin activates a signaling pathway leading to decreased
cellular proliferation and that ligation of this receptor with fibronectin reverses this
signal, thereby contributing to the proliferation of transformed cells.
INTRODUCTION
Regulation of cellular proliferation and the cell cycle is
a complex phenomena that incorporates the coordi-
nated activities of cyclins (Nurse, 1990; Ohtsubo and
Roberts, 1993), serine/threonine kinases (Kikkawa et
al., 1989; Norbury and Nurse, 1989; Boulton et al., 1991;
Koff et al., 1993), growth factor receptor tyrosine ki-
nases (Yarden and Ullrich, 1988; Ullrich and Schless-
inger, 1990), src family tyrosine kinases (Hanks et al.,
1988; Cantley et al., 1991), transcription factors (Cole,
1986; Rollins and Stiles, 1989; Blackwood and Eisen-
man, 1991; Hofbauer and Denhardt, 1991; Lewin, 1991;
Smith and Prochownik, 1992), and effector molecules
such as phosphatidylinositol triphosphate and cal-
cium (Berridge, 1984, 1993). Normal cells can be in-
duced to withdraw from the cell cycle and to become
quiescent by maintenance in anchorage-independent
conditions (Dike and Farmer, 1988). They are depen-
dent on anchorage not only for growth (Dike and
Farmer, 1988) but also for survival (Meredith et al.,
t Corresponding author: 327 Via Andalusia, Encinitas, CA 92024.
1993; Brooks et al., 1994; Montgomery et al., 1994). In
contrast to normal cells, tumor cells and virally trans-
formed cells are characterized by anchorage-indepen-
dent growth.
Anchorage-independent growth likely results from
an uncoupling of cell cycle dependence on signals
transduced by attachment to the substratum (Guad-
agno et al., 1993). Loss of the cell's normal adhesive
factors may be a cause or a consequence of this alter-
ation in cell cycle regulation. The adhesion protein
fibronectin was originally characterized as "Large Ex-
ternal Transformation Sensitive" protein (LETS), as it
is lost from the surface of transformed cells (Vaheri
and Ruoslahti, 1975; Mautner and Hynes, 1977). Loss
of binding of fibronectin to the cell surfaces of some
transformed cells (Wagner et al., 1981) was later sug-
gested to result either from a transformation-associ-
ated loss of surface expression of integrin a5f31, the
fibronectin receptor (Plantefaber and Hynes, 1989), or
from an inactivation of the integrin a5f31 via a phos-
phorylation event (Hirst et al., 1986). That the expres-
sion and function of the integrin a5f31 can actively
regulate proliferation was demonstrated by a series of
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studies of tumor variants that displayed altered a5f31
expression. Variants of MG63 osteosarcoma cells
(Dedhar et al., 1987, 1989) and K562 erythroleukemia
cells (Symington, 1990) selected for increased ability to
attach to fibronectin exhibited a fivefold up-regulation
of a5f31 expression and displayed significantly re-
duced growth in assays of anchorage-independent
growth and tumorigenicity. Additionally, Chinese
hamster ovary cells expressing 30-fold normal levels
of a5f31 by gene transfection displayed completely
suppressed tumorigenicity and partially suppressed
in vitro growth (Giancotti and Ruoslahti, 1990). In
addition, total loss of integrin a5031 expression in Chi-
nese hamster ovary cells enhances tumorigenicity
(Schreiner et al., 1991b). Thus, integrin a5,31 expres-
sion can suppress growth in cells that overexpress it.
The mechanism by which a5131 suppresses growth
remains unknown. It is known, however, that upon
ligation with fibronectin, a5f31 transduces signals
across the membrane (Hynes, 1992; Juliano and
Haskill, 1993). Among the integrin-generated signals
identified to date are increases in intracellular pH
(Schwartz et al., 1989-1991; Schwartz and Lechene,
1992), increases in intracellular calcium (Pelletier et al.,
1992; Schwartz, 1992; Leavesley et al., 1993), and in-
creases in inositol lipid synthesis (McNamee et al.,
1993), tyrosine phosphorylation of a 125-kDa tyrosine
kinase associated with focal contacts, ppl25 FAK
(Kornberg et al., 1991; Guan and Shalloway, 1992), and
activation of p34/cdc2 (Symington, 1993) and cycin A
(Guadagno et al., 1993). We examined the mechanism
by which a5f31 negatively regulates proliferation with
HT29 colon carcinoma cells transfected with the
cDNA for the integrin a5 subunit. We demonstrate
that in the absence of a fibronectin substrate, a5131
transduces signals that negatively regulate cellular
proliferation. This growth suppression is associated
with an up-regulation of the growth arrest-inducing
gene, gas-1 (Del Sal et al., 1992, 1994) and a down-
regulation of the immediate early genes c-fos, c-jun,
and jun B.
MATERIALS AND METHODS
Transfection and Cell Culture
HT29 colon carcinoma cells were obtained from the American Type
Culture Collection (Bethesda, MD) and were routinely cultured in
DMEM (high glucose formulation), 10% fetal bovine serum, and
gentamicin (50 ,ug/ml). One million HT29 cells in monolayers were
washed three times with warmed DMEM without serum, and over-
laid for 12 h with a 1:1 (w/w) suspension of lipofectin (Life Tech-
nologies, Gaithersburg, MD) and 40 ,ug of the vector pECEa5 and 4
,ug of pSVneo that had been previously linearized by digestion with
the restriction enzyme PvuII. The cells were cultured in complete
medium for an additional 48 h, and thereafter in complete medium
containing 1 mg/ml of the antibiotic G418. Antibiotic-resistant col-
onies were selected and clonally expanded over a 2-mo period. a5
positive colonies were identified by flow cytometric analyses and
verified by immunoprecipitation analyses. Colonies displaying
identical levels of surface a5031 exhibited identical properties in all
experiments. The expression vector pECEa5 was a gift from Dr.
Erkki Ruoslahti, La Jolla Cancer Research Foundation, La Jolla, CA.
Flow Cytometry
HT29 cells were harvested from tissue culture flasks with a brief
trypsin-EDTA treatment, resuspended, and washed three times in
cold medium containing 1% bovine serum albumin (BSA). Five
hundred thousand cells were incubated for 30 min on ice in 10 jig of
isotype-matched control antibodies or B1E5 (anti-a5), AIIB2 (anti-
31), GoH3 (anti-a6), P1H5 (anti-a2), or P1B5 (anti-a3) antibodies.
Cells were washed three times in DMEM containing 1% BSA and
incubated in fluorescein-labeled secondary antibodies for 30 min on
ice. Cells were then washed three times with phosphate-buffered
saline (PBS), fixed in 0.5% paraformaldehyde in PBS and analyzed
by flow cytometry. Anti-human a5 (B1E5) and anti-human l31
(AIIB2) were gifts from Dr. Carolyn Damsky, University of Califor-
nia at San Francisco; anti-human a2 (PlH5) and anti-human a3
(PlB5) were gifts from Dr. William Carter, University of Washing-
ton at Seattle; anti-human a6 (GoH3) hybridoma supernatants were
a gift from Dr. Arnould Sonnenberg, Netherlands Cancer Research
Center; and anti-human av (LM142) and av133 (LM609) were from
Dr. David Cheresh, Scripps Research Institute, La Jolla, CA.
Inhibition of Adhesion Assays
The wells of 96-well microtiter plates were coated with 10 ,ug/ml of
fibronectin (Collaborative Biomedical Research, Becton Dickinson
Labware, Bedford, MA) for 2 h at 37°C. The wells were then blocked
by incubation in 3% BSA in PBS. Cells were removed from tissue
culture dishes by incubation in versene, washed three times in
DMEM containing 3% BSA, 2 mM CaCl2, and 2 mM MgC12 at 5 x
105 cells/ml. Equal volumes of cells and antibody or peptide solu-
tions at 2x final concentration were added to microtiter plate wells
and cells were allowed to adhere for 1 h at 37'C. Wells were then
washed four times with warmed adhesion buffer and rinsed once
with PBS. Cells were fixed for 15 min in 0.5% paraformaldehyde in
PBS, and were stained with a solution of 0.5% crystal violet in 20%
methanol for 1 h at room temperature. Stained cell layers were
washed with water and bound dye was solubilized with 1% sodium
dodecyl sulfate in water. Absorbance was determined at 540 nm.
Data is represented as percentage of total cells bound in the absence
of any inhibitor. Antibodies used to inhibit adhesion are described
under "Flow Cytometry." Goat anti-integrin a5,B1 antiserum gp 140
was developed in the laboratory of R.L. Juliano.
Adhesion Assays
The wells of 96-well microtiter plates were coated with serial dilu-
tions of a 100 ,ug/ml solution of matrix protein (fibronectin, colla-
gen, vitronectin, or laminin) for 2 h at 37°C and blocked in 3% BSA
in PBS. Cells were removed from tissue culture dishes by incubation
for a brief period in versene, then washed three times by centrifu-
gation and resuspension in DMEM containing 3% bovine serum
albumin, 2 mM CaCl2, and 2 mM MgCl2 at 5 x 105 cells/ml. Cells
were added to wells of the coated plates and allowed to adhere for
60 min at 37°C. Unbound cells were removed by washing four times
with warmed adhesion buffer and plates were processed as de-
scribed for inhibition of adhesion assays.
Tumorigenicity Assays
Aliquots of 5 x 105 or 5 x 106 cells of HT29 parental cells, pSVneo-
transfected clone 1, and a5-expressing clones 34 and 30 were in-
jected subcutaneously into the flanks of 10 female athymic nude
mice per clone. Tumor dimensions were assessed with the aid of
calipers every third day and animals were killed as tumors reached
an approximate size equivalent to 1000 mm3. Average tumor vol-
umes = (width2 X length)/2 in mm3 were determined. The statis-
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tical significance of the difference in growth between pSVneo-trans-
fectants and a5 transfectants was evaluated on the basis of Student's
t-test.
In Vitro Growth Assays
a5-positive and -negative pSVneo transfectants were seeded at 5 x
104 cells/ml in DMEM supplemented either with serum or, in the
absence of serum, with insulin, transferrin, and selenium (ITS pre-
mix) in triplicate wells of 12-well tissue culture dishes. Some dishes
were coated with matrix protein (25 ,ug/ml fibronectin or vitronec-
tin in PBS for 1 h at 37°C followed by blocking in 3% BSA in PBS).
Cells were cultured for up to 8 days, renewing the medium every 3
days. Total cell number was determined by removal of cells from
the dishes with trypsin-EDTA and counting in an electronic particle
counter (Model 80H, Particle Data, Elmhurst, IL). The mean of
triplicate determinations for each day of growth and standard de-
viations from the mean were determined.
Thymidine Incorporation Determinations
The wells of a 96-well microtiter culture plate were coated either
with no matrix protein or with 10 jig/ml solutions of fibronectin or
polyL-lysine for 2 h at 37°C followed by incubation overnight at 4°C
in 3% BSA in PBS. PSVneo-transfectant clone 1 and a5-positive
transfectant clone 30 were resuspended at 106 cells/ml after re-
moval from tissue culture flasks with versene and washing three
times in warmed serum-free DMEM medium containing 3% BSA, 2
mM MgCl2, and 2 mM CaCl2. Cells were resuspended in warmed
serum-free DMEM containing 2 mM CaCl2, 2 mM MgCl2, ITS pre-
mix, and 10 ,uCi [3H]thymidine/milliliter of culture medium. One
hundred thousand cells (100 ,ul) were aliquoted into triplicate wells
per condition and cultured at 37°C for 24 h. The culture medium
was removed, cells were washed three times by centrifugation with
culture medium, and acid perceptible counts were determined.
Reverse Transcriptase Polymerase Chain Reaction
(PCR) Analyses
Aliquots (106 cells) of a5 positive and pSVneo transfectants were
removed from culture dishes, washed, and seeded in 1 ml of DMEM
supplemented with serum or with insulin, selenium, and transferrin
premix in wells of 12-well culture plates for 3, 7, 9, 12, 17, 24, 48, or
72 h before harvesting. Cells that had been maintained in suspen-
sion for these times were also cultured for 1-24 h on tissue culture
wells that had been coated with 100 ,ug/ml of fibronectin, polyL-
lysine, collagen, or vitronectin essentially as described for adhesion
assays. RNA was isolated according to the method of Chomczynski
and Sacchi (1987). First strand cDNA was synthesized by incubating
up to 2 ,ug of RNA in 10 mM Tris, pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 1.25 mM each of deoxyadenosine triphosphate (dATP), de-
oxycytidine triphosphate (dCTP), deoxythymidine triphosphate
(dTTP), and deoxyguanidine triphosphate (dGTP), 10 pmol random
hexamer primers, and 25 U of AMV reverse transcriptase in a final
volume of 20 ,ul for 60 min at 42°C followed by 10 min at 65°C.
cDNA was diluted to 100 ,ul with Tris-EDTA. PCR amplification of
gene products was performed using 2.5 ,ul of first strand cDNA in
a final volume of 50 ,ul of 10 mM Tris, pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 1.25 mM each of dATP, dCTP, dTTP, and dGTP, and 0.5 ,ul
of TAQ polymerase with 50 pmol each of forward and reverse
primers for 35 cycles in a thermocycling apparatus with annealing at
56°C. Twenty percent of the PCR products was resolved by electro-
phoresis on 2% Tris-borate-EDTA agarose gels. Each PCR analysis
was performed in duplicate on identical samples under nonsaturat-
ing conditions; each experiment was repeated at least three times.
Amounts of starting material were standardized on the basis of
amounts of actin product by performing successive rounds of
PCR, adjusting the concentration of starting cDNA until equal
amounts of actin product were obtained for each sample to be
compared. The appropriate dilutions used to obtain equal
amounts of actin product were used to compare PCR products for
other PCR primers. The use of actin as an internal standard for
PCR is well documented (Schmitt et al., 1991; Lewis et al., 1993).
PCR primers for the growth factor messages PDGF, TNF-a,
TGF-,B, TGF-a, and EGF were purchased from Clontech Labora-
tories (Palo Alto, CA). PCR primers as follows:
for growth arrest-specific gene-1: 5' TGCGAATCGGTCAAA-
GAGAAC 3' and 5' AGCAACAGCAGCAGCAAACAG 3'
for c-jun: 5' GGAAACGACCTTCTATGACGATGCCCTCAA 3'
and 5' GAACCCCTCCTGCTCATCTGTCACGTTCTT 3'
for c-fos: 5' GAATAAGATGGCTGCAGCCAAATGCCGCAA 3'
and 5' CAGTCAGATCAAGGGAAGCCACAGACATCT 3'
for c-myc: 5' TGTCTCAGGACTCTGACACTGTCCAACTTG 3'
and 5' CTGGCAAAAGGTCAGAGTCTGGATCACCTT 3'
for jun B: 5' CCAGTCCTTCCACCTCGACGACGTTTACAAG 3'
and 5' GACTAAGTGCGTGTTTCTTTTCCACAGTAC 3'
for histone: 5'GAGGAAAGGGCGGAAAAGGCTTAGGCAAAG
3' and 5' CAAAAAGGGCCTTTGGGATGGAAACGTGCA 3'
for p53: 5' TACAAGCAGTCACAGCACATGACGGAGGTT 3'
and 5' AGTTGTAGTGGATGGTGGTACAGTCAGAG 3'
for Harvey ras: 5' ACCATCCAGCTGATCCAGAACCATTTTGTC
3' and 5' CTGTACTGGTGGATGTCCTCAAAAGACTTG 3'
PCR primers for gas-i were designed with the aid of a sequence
analysis program, primers for actin were the gift of Dr. Steve
Haskill, and primer sequences for the other transcripts were taken
from Irving et al. (1992). PCR product sizes were: gas-1 (322 bp),
actin (150 bp), c-fos (236 bp), p53 (220 bp), c-jun (325 bp), jun B (257
bp), c-myc (187 bp), Hras (233 bp), and histone H4 (347 bp).
RESULTS
Expression of a5f31 on HT29 Colon Carcinoma
Previous studies have demonstrated that overexpres-
sion of the integrin a5f31 suppresses the proliferation
of transformed cells (Dedhar, 1987, 1989; Giancotti
and Ruoslahti, 1990; Symington, 1990). To examine the
mechanism by which the integrin a5f31 regulates pro-
liferation, integrin a5f31 negative colon carcinoma
cells were co-transfected with linearized eukaryotic
expression constructs containing the intact cDNA for
the human integrin a5 subunit (pECEa5) and the neo-
mycin resistance gene (pSVneo). Parental HT29 hu-
man colon carcinoma cells (from the Duke's stage I
adenocarcinoma HT29 cell line) do not express the
integrin a5f31 (Schreiner et al., 1991a) as assessed by
flow cytometry (Figure 1A) and immunoprecipitation
analyses (our unpublished observations).
Like parental HT29 cells, HT29 cells transfected only
with the neomycin resistance gene (pSVneo transfec-
tants) do not express the integrin a5f31 (Figure 1B) and
do not adhere to a fibronectin substratum (Figure 2A).
After transfection of HT29 cells with the a5 gene, a5/31
surface expression could be demonstrated by flow
cytometric analyses (Figure 1B) and immuno-precipi-
tation analyses (our unpublished observations). Sur-
face expression of a5f31 did not significantly alter the
expression of other integrin subunits, as no significant
change in surface expression levels of other integrin
subunits (,31, a2, a3, and a6) were noted by FACS
(Figure 1C) or (,f1, a2, a3, a6, av, and f35) immuno-
precipitation analyses (our unpublished observa-
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tions). These results indicate that transfection of HT29
cells with a5 does not deplete the j31 subunit intracel-
lular pool such that it alters surface expression or
function of other a subunits.
The de novo expression of the integrin a5 subunit in








Figure 1. HT29 transfectants express a5f31 on the cell surface. (A
and B) Flow cytometric analyses of a5p31 expression on HT29 pa-
rental cells (A) and on representative G418-resistant HT29 clone 30
(ca5 positive, panel B) and clone 1 (ca5 negative, panel B) were
performed as described in MATERIALS AND METHODS with
anti-a5 monoclonal antibody B1E5 (ca5) and anti-,l monoclonal
antibody AIIB2 ((31). A nonspecific same species IgG served as a
negative control (neg). FACS analysis diagrams are plots of relative
cell number (0-10,000) on the y-axis vs. relative fluorescence on the
x-axis. (C) Flow cytometric analyses of integrin subunits (a2, ca3, a6,
and ,31) on clones 30 and 1 were performed as described in MATE-
RIALS AND METHODS, with an anti-ca2-specific monoclonal anti-
body P1H5 (a2), anti-a3-specific monoclonal antibody P1B5 (c3),
and anti-a6-specific antibody GoH3 (ca6). Nonspecific same species
IgG was used as negative control antibody (neg).
a fibronectin substrate (Figure 2A). Parental and pSV-
neo-transfected HT29 cells are unable to adhere to
fibronectin (Schreiner et al., 1991a; Figure 2A). The a5p1
integrin positive transfectants, however, exhibit signif-
icant adhesion to fibronectin (Figure 2A). No changes
were observed in adhesion to other substrates, such as
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Figure 2. HT29 transfectants adhere to fibronectin via a531. HT29 transfectants (5 x 104 cells) were allowed to adhere for 30 min to the wells
of a microtiter plate coated with serial dilutions of a starting solution of 100 ,ug/ml of fibronectin (A), collagen (B), or laminin (C). Percent
of adhesion was determined as described in MATERIALS AND METHODS and was graphed vs. concentration of ligand. (D) HT29
transfectants (5 X 10' cells) were allowed to adhere for 30 min to the wells of a microtiter plate coated with 10 ,Lg/ml of fibronectin in the
absence or presence of 10 jig/ml of anti-a5 monoclonal antibody BlE5, anti-,31 monoclonal antibody AIIB2, anti-a3 monoclonal antibody
PlB5, anti-avf33 monoclonal antibody LM609, anti-av monoclonal antibody LM142, anti-a5131 polyclonal antibody gp-140, 2.5 mM GRGDSP
or 2.5 mM GRGESP, or 10 mM EDTA. Percent of adhesion was assessed as described in MATERIALS AND METHODS.
collagen, laminin (Figure 2, B and C), and vitronectin
(our unpublished observations), indicating that the
presence of the fibronectin receptor does not perturb
normal HT29 integrin-mediated adhesion to other ex-
tracellular ligands. This de novo adhesion of a5 HT29
transfectants to fibronectin can be attributed entirely
to the newly expressed a531 integrin because adhesion
of these cells to fibronectin was completely inhibited
by the divalent cation chelator, EDTA (Figure 2D), as
well as significantly by function-blocking anti-:1 and
anti-a5 antibodies (70% inhibition). Moreover, a poly-
clonal anti-a531 antibody completely blocked adhe-
sion to fibronectin. Several function-blocking mono-
clonal antibodies directed against other integrin
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subunits (a2, a3, a6, avf33, and av) and isotype-
matched control antibodies failed to inhibit adhesion
of these cells to fibronectin. GRGDSP, the smallest
fibronectin peptide sequence recognized by integrin
receptors for fibronectin, but not the control peptide
GRGESP, also significantly inhibited (by 70%) adhe-
sion to fibronectin. Adhesion to fibronectin in colon
carcinoma cells is thus strictly a property of the ec-
topically expressed integrin a5f1.
Inhibition of Tumorigenicity
Previous studies have suggested that a5f31 expression
on cells is associated with reduced tumorigenicity. To
examine whether de novo expression of a5f31 on HT29
cells impacted their tumorigenicity, pSVneo and a5
transfectants were injected into nude mice. As shown
in Figure 3, expression of a5p1 on the cell surface led
to complete suppression of tumor formation when 5 x
105 colon carcinoma cells were inoculated subcutane-
ously into athymic nude mice (Figure 3A). When mice
were inoculated with 10-fold higher doses (5 x 106) of
pSVneo transfectant clone 1 and a5-positive transfec-
tant clones 34 and 30, a5-positive transfectants formed
tumors, but at a significantly slower rate than did
pSVneo transfectants (Figure 3B). Doubling times for
the a5 tumors from clones 30 and 34 are at least twice
those of control transfectant and wild-type tumors
(Table 1). Similar results were obtained in each of
several identical tumorigenicity experiments. Flow cy-
tometric analyses of cells explanted from tumors indi-
cated that their integrin phenotypes had not changed
while growing as tumors (our unpublished observa-
tions).
The a5-positive tumors that did grow were not only







entiated phenotype than those of the pSVneo transfec-
tants (Figure 3C). When sections of tumors were
stained with Alcian blue and counterstained with he-
matoxylin, tumors from the a5-positive clones 30 and
34, but not from the pSVneo transfectant clone 1,
exhibited significant numbers of Alcian blue-stained
deposits, which is indicative of increased mucin or
proteoglycan deposition (Figure 3, arrows), a charac-
teristic of differentiated colon epithelia (Huet et al.,
1987; Lesuffleur et al., 1991; McNeal et al., 1991). All
a5-positive tumors had similar morphologies to those
shown here for clones 30 and 34. Thus, a5 expression
leads to significant in vivo growth suppression in
these carcinoma cells and may also lead to increased
differentiation as evidenced by enhanced mucin secre-
tion and altered morphology.
In Vitro Proliferation Is Dependent on Adhesion to
Fibronectin
To determine whether a5131 expression also alters the
in vitro proliferation of HT29 cells, we compared the
in vitro proliferative rates of a5131 transfectants and
pSVneo transfectants under a variety of growth con-
ditions. When cultured in the presence of serum for 7
days, a5-positive transfectants initially exhibit a
growth lag compared with pSVneo transfectants (Fig-
ure 4A), but eventually double at the same rate
(29.5-32 h) as the pSVneo transfectants (Table 1). The
growth rate of parental HT29 cells under these condi-
tions is identical to that of pSVneo transfectants (our
unpublished observations). a5 transfectants, however,
reproducibly reach saturation inhibition of growth at a
two- to threefold lower density than do control trans-
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Figure 3 cont. Tumor growth and
morphology is altered in integrin
ai51l-positive HT29 transfectants.
(A) Athymic nude mice were inoc-
ulated with aliquots of 5 X i0' cells
of HT29 a5-negative clone 1, and
a5-positive clone 30. Tumor di-
mensions were measured at regu-
lar intervals over 10 wk and aver-
age tumor volume was calculated
as described in MATERIALS AND
METHODS. Each point represents
the mean of tumor growth in 10
mice each. (B) Athymic nude mice
were inoculated with aliquots of 5
X 106 cells of HT29 a5-negative
clone 1, and ai5-positive clones 30
and 34. Tumor dimensions were
easured at regular intervals over
6 wk and average tumor volume
was calculated as described in MA-
TERIALS AND METHODS. Each
point represents the mean of tumor
growth in 10 mice each. (C) End-
point tumors (1 cm3 in volume)
from clones 1, 30, and 34 were
fixed, sectioned, and stained with
Alcian blue and hematoxylin. Rep-
resentative sections of slides were
photographed at 20X magnifica-
tion. Arrows indicate Alcian blue-
g~~~~~~~~~~~~~~~~~~~~~~~~~~ratv inclusions.|
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Table 1. In vivo and in vitro doubling times
In vitro:
Clone In vivo Serum No serum No serum, FN No serum, VN
Parental 8d ± ld 30 h ± 2h 48h ± 2h
1 8d ± ld 29.5h ± 2h 48h ± 3h 46h ± 2h 48h ± 2h
34 17d ± ld 32 h ± 3h 75h ± 3h 48h ± 2h >72h ± 2h
30 17d ± ld 32 h±Ih 72h ± 2h 48h ± 2h >72h ± 2h
Mean tumor volume doubling times were determined for the HT29 parental cell line and for transfectant tumors in in vivo growth studies
in athymic nude mice over the course of a 60-day period, as described in Figure 3B. Mean cell number doubling times for the HT29 parental
cell line and transfectants in in vitro growth studies in the presence of serum, in the absence of serum, and in the absence of serum on a
fibronectin and a vitronectin substratum were determined over the course of 8 days in culture.
absence of serum in a defined medium containing
insulin, transferrin, and selenium supplements,
a5p1l-positive transfectants double at a significantly
slower rate (72-75 h) than do pSVneo transfectants
(48 h) (see Figure 4B and Table 1). Under these
conditions, a5-positive transfectants but not pSVneo
transfectants eventually cease to proliferate during
an 8-day period. Neither cell type adheres to the
substratum during culture in serum-free media,
suggesting that the cells do not secrete fibronectin or
other matrix proteins.
Cell growth was examined after cells were allowed
to attach to fibronectin and other matrix proteins. As
shown in Table 1, adhesion to a fibronectin-coated
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growth inhibition displayed by a5-positive transfec-
tants. These transfectants can be induced to proliferate
at the same rate as pSVneo transfectants by adhesion
to fibronectin. This effect appears to be specific for
a5f31 because adhesion to vitronectin fails to reverse
the growth inhibition (Table 1). Only a5-positive
transfectants attached, spread, and grew as monolay-
ers on fibronectin, whereas both a5-positive and -neg-
ative cells grew as monolayers on vitronectin (but at
different rates). Immunohistochemical staining as well
as immunoprecipitation analyses of tumors and cells
in culture (our unpublished observations) for fi-
bronectin expression indicates that neither pSVneo-
transfectants nor a5-positive transfectants express or
secrete any fibronectin. Thus, in the absence of an
B
10








Figure 4. Integrin a5131 expression inhibits in vitro growth only in the absence of attachment to fibronectin. a5-negative clone 1 and
a5-positive clone 30 cells were seeded at equal densities (5 x 104 cells/ml) in triplicate wells of 12-well tissue culture dishes in the presence
of serum (A) or in serum-free medium supplemented only with insulin, selenium, and transferrin on tissue culture plates blocked with BSA
(B). Total cell number was determined over a 6- to 8-day period by removal of cells from the dishes with trypsin-EDTA followed by counting
in an electronic particle counter.
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exogenously added fibronectin substrate, the a5 trans-
fectants remain unattached to fibronectin.
The reduced proliferation of a5-positive cells in the
absence of a fibronectin substrate may be a conse-
quence of a failure of the cell to progress through the
cell cycle to S phase. HT29 a5t31-positive transfectants
are unable to incorporate significant amounts of triti-
ated thymidine in serum-free culture compared with
pSVneo transfectants (Figure 5). Only 20% of the
amount of thymidine incorporated by pSVneo trans-
fectants is incorporated by a5-positive transfectants in
the absence of a5131-mediated adhesion (Figure 5, ITS
medium and polyL-lysine). As reflected by the in vitro
growth studies, a5-positive cells are stimulated to re-
verse this block in cell cycle progression by adhesion
to fibronectin but not by adhesion to other substrates.
a5-positive transfectants allowed to adhere to fibro-
nectin in the absence of serum incorporate nearly the
same levels of thymidine incorporated by pSVneo-
transfected cells in all serum-free culture conditions
(Figure 5, fibronectin).
ax5f81 Expression Is Associated with Enhanced Gas-1
Transcription and Down-regulation of Immediate
Early Gene Transcription
To account for the effects of a5,31 expression and
ligation on cell growth, we examined a number of
transcriptional events known to be associated with
80000 -
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Figure 5. Thymidine incorporation by HT29 a5 transfectants is
inhibited in the absence of attachment to fibronectin. PSVneo and
a5-positive transfectants were maintained in culture in complete
medium, in suspension culture in medium supplemented only with
insulin, selenium, and transferrin (ITS medium), or in medium
supplemented with insulin, transferrin, and selenium on tissue
culture plastic that had been coated with 25 ,ug/ml fibronectin
(fibronectin) or polyL-lysine (poly-l-lysine) in the presence of 10
,ug/ml tritiated thymidine at 5 x 104 cells/ml for 24 h and acid
precipitable counts were determined.
cellular proliferation. Reverse transcriptase PCR anal-
ysis was performed to monitor potential alterations in
gene expression patterns between a5f31 and pSVneo
transfectants. All analyses were performed on samples
adjusted to yield equal amounts of an actin PCR
product under nonsaturating conditions from at
least three different experiments. Identical patterns
of expression were observed for each of the a5-
positive clones studied.
Expression of the integrin a5l3i did not alter the
pattern of expression of growth factors secreted by
HT29 cells when cultured in the presence or absence of
serum (Figure 6). Levels of TGF-a, TGF-,3, EGF, PDGF,
and TNF-a messages remain unchanged. In contrast,
expression of a5131 in the absence of attachment to a
fibronectin substrate on HT29 cells (i.e., during culture
in the absence of interaction with fibronectin substra-
tum) induces expression of mRNA for a growth ar-
rest-associated protein, growth arrest-specific gene-1
(gas-1; Del Sal et al., 1992, 1994). Gas-1 was first iden-
tified in serum-starved fibroblasts as a growth arrest-
inducible transcript that is regulated independently
from the immediate early genes c-fos and c-jun. Gas-1
was also shown to induce growth arrest when intro-
duced into either normal or transformed cells (Del Sal
et al., 1992, 1994). After 12 or more hours of culture in
the absence of adhesion, a5-positive cells, but not
a5-negative cells, begin to transcribe gas-1 and con-
tinue to transcribe it for at least 72 h, the latest time
point examined (Figure 7). These results suggest that
expression of aSB3 in the absence of attachment in-
duces expression of a gene product, gas-1, that has
been shown to contribute directly to long-term with-
drawal from the cell cycle.
In addition to the enhanced gas-1 expression, a5-
positive cells but not pSVneo transfectants down-reg-
ulate c-fos, c-jun, and jun B transcription when cells are
cultured in vitro in the absence of serum for up to
36 h (Figure 8A). Actin, H-ras, p53, histone, and c-myc
transcription remain unchanged under these condi-
tions. Expression of c-fos and c-jun is significantly
down-regulated and jun B expression is completely
inhibited (Figure 8A).
C-fos, c-jun, and jun B expression are rapidly down-
regulated in a time course of response that is distinct
from gas-1 expression. For example, c-fos, but not c-
myc, expression is down-regulated within 3 h of re-
moving a5-positive cells from contact with the sub-
stratum and remains down-regulated for up to 72 h,
the latest time point examined. Only a5-positive cells
display a c-fos transcriptional response to the induc-
tion of suspension culture (Figure 8B). Thus, a5f31
expression in the unligated state is associated not only
with an increased transcription of gas-1, but also with
decreased transcription of immediate early genes reg-
ulating proliferation.
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Figure 6. Expression of growth factors is unaltered in a5-positive
transfectants. PSVneo (a5-) and a5-positive (a5+) transfectants
were maintained in serum or serum-free culture over a period of 24 h.
RNA was isolated and first strand cDNA was synthesized. PCR
amplification of gene products was performed with primers specific
for TGF-a, TGF-,B, PDGF, EGF, and TNF-a at 56°C after standard-
ization of cDNA levels for actin message levels. Results were ana-
lyzed by electrophoresis on TBE 2% agarose gels with molecular
weight markers (1353, 1078, 872, 603, 310, 281, 271, 234, 194, 118, and
72 bp) and ethidium bromide-stained products were photographed.
Adhesion to Fibronectin Reverses Gene Expression
Changes
To examine the effect of ligation of a5f31 with fibronec-
tin on the transcriptional regulation of gas-1 and im-
mediate early genes, a5131 cells were allowed to ad-
here to fibronectin or other substrates and gene
expression was examined. As shown in Figure 9A, the
decrease in c-fos expression levels can be reversed and
returned to the levels exhibited by pSVneo transfec-
tants by adhesion to fibronectin, but not to other ad-
hesive substrates. a5-positive cells up-regulate c-fos
expression within 1 h of adhesion to fibronectin,
whereas expression of other gene products (actin, hi-
stone H4, and c-myc) remains unchanged and identical
to the levels expressed by pSVneo transfectants. In
addition, gas-1 expression is down-regulated by adhe-
sion to fibronectin, but only after 3 h of adhesion
(Figure 9B). Adhesion to other substrates such as
polyL-lysine or other matrix proteins does not induce
these alterations in gene expression (Figure 9C). Thus,
integrin a5,31 is capable of generating both positive
and negative signals depending on the adhesive state
of the cell.
These results indicate that ectopic expression of
a5,31 in HT29 colon carcinoma cells alters gene expres-
sion events that directly impact cellular proliferation.
The integrin a5,31-mediated growth inhibition that
we describe here and that others have previously de-
scribed (Giancotti and Ruoslahti, 1990) appears to be
mediated by the unattached integrin and can be re-
versed only through ligation of the integrin by adhe-
sion to fibronectin.
DISCUSSION
Regulation of cellular proliferation is a complex phe-
nomenon, which requires the precise and timely inter-
play of a variety of signaling and transcription events.
The roles of growth factors and their receptors in the
regulation of the cell cycle have been the subjects of
much scrutiny (Ullrich and Schlessinger, 1990; Hof-
bauer and Denhardt, 1991). In contrast, the contribu-
tion of anchorage to the substratum to the regulation
of proliferation is not as well understood (Juliano and
Haskill, 1993). As members of several families of cell
adhesion receptors (integrins, cadherins, and Ig super-
family CAMs) are increasingly studied, their roles in
the life cycle of cells are being elucidated. In the stud-
ies presented here, we have shown that the integrin
a5f31 exerts a dominant negative effect on cellular
proliferation. The same integrin, however, permits
proliferation upon cell attachment to a fibronectin sub-
strate. These findings provide the first evidence that
both ligated and unligated integrin transduce signals
that differentially regulate transcription.
HT29 colon carcinoma cells normally do not express
the integrin a5f31 and do not adhere to fibronectin.
Transfection of these cells with the gene for the inte-
grin a5 subunit allowed us to examine the role of this
integrin and its interactions with the extracellular ma-
trix ligand fibronectin in the regulation of prolifera-
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tion. Surface expression of a5/31 enabled cells to ad-
here to a fibronectin substrate without apparently
altering the expression or function of other integrins.
Although monoclonal antibodies and RGD peptides
significantly blocked the adhesion of the a5 transfec-
tants to fibronectin (70%), complete inhibition was not
achieved. It is possible that the levels of added block-
ing antibody or peptide were not sufficient in these
experiments to completely inhibit adhesion, because
an anti-a531 polyclonal antibody did completely in-
hibit adhesion. Alternatively, it is also possible that
other fibronectin receptors such as avfl or av136 have
been induced or activated through integrin-crosstalk
(Blystone et al., 1994) in the a5-transfected cells and
may contribute to the de novo adhesion to fibronectin.
In addition to exhibiting de novo adhesion to fi-
bronectin, the a5f31 transfectants, but not pSVneo
transfectants, became dependent for proliferation on
anchorage to fibronectin, apparently via their integrin
a5f31. a5f31 transfectants were unable to proliferate as
well as their pSVneo transfected counterparts in vivo
or in vitro in the absence of attachment to fibronectin.
In fact, the temporary growth lag exhibited by HT29
a5-positive transfectants after they are placed into
serum culture may result from a temporary with-
drawal from the cell cycle that is induced by their
removal from the fibronectin substratum that is
present in serum culture. Incorporation of soluble fi-
bronectin at physiologically relevant concentrations
alpha5
hours
(25 ,ug/ml, approximately the amount of fibronectin
or vitronectin present in a 10% serum culture me-
dium) into the serum-free growth medium fails to
reverse the growth inhibition displayed by a5-positive
or pSVneo transfectants (Varner and Juliano, unpub-
lished results). Although soluble fibronectin has been
shown to interact with the fibronectin receptor, it does
so poorly, requiring very high (5-10 mg/ml), non-
physiologically relevant concentrations of fibronectin
(Yamada and Kennedy, 1984). These results suggest
that interaction of the integrin a55p1 with a fibronectin
substratum is needed to permit the a5-positive cells to
proliferate. Although the a5f31 on the surface of sus-
pended cells is not occupied by fibronectin, it is pos-
sible that it is occupied by as yet unknown surface or
secreted components that could participate in the
a5f31-induced negative growth regulation.
The a5 transfectants proliferate in serum-free, insu-
lin-supplemented media as well as their control-trans-
fected counterparts only when cultured on a fibronec-
tin substrate. Although many a531-positive cell types
grow well on vitronectin and other matrices in serum
or in defined media, the HT29 a5 transfectants do not
grow well on vitronectin in insulin-supplemented, se-
rum-free media. It is possible that other growth con-
ditions (i.e., other growth factor supplements) would
induce these cells to proliferate on vitronectin and
other matrices. Recent studies suggest that specific
growth factors collaborate with distinct integrins to
1
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Figure 7. Growth arrest specific gene-I is
expressed a5 positive transfectants in the
absence of attachment to fibronectin. PSV-
neo (a5-) and a5-positive (a5+) transfec-
tants were maintained in suspension culture
over a period of 24 h. RNA was isolated at
time points of 3, 9, 17, and 24 h after initia-
tion of suspension culture and first strand
cDNA was synthesized. PCR amplification
of gene products was performed with prim-
ers specific for gas-I (322 bp) and actin (150
bp) at an annealing temperature of 56'C as
described in MATERIALS AND METH-
ODS. Results were analyzed by electro-
phoresis on 2% TBE agarose gels with mo-
lecular weight markers (1353, 1078, 872, 603,
310, 281, 271, 234, 194, 118, and 72 bp) and
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A Stds actin H-ras histone p53 c-fos c-jun JUN B c-myc guretranscr iate earlyJUNBc-myc ~~gene transcription is down-
+ - + + + + + + + a 5 regulated in a5-positivetransfectants. (A) PSVneo
(a5-) and a5-positive (a5+)
transfectants were cultured
in suspension for 24 h before
isolation of RNA and syn-
thesis of first strand cDNA
as described in MATERIALS
AND METHODS. PCR anal-
yses for expression of gene
products was performed at
! | | * * ttl56°C using primers specific
for actin (150 bp), H-ras (233
bp), histone H4 (347 bp), p53
B hours in suspension 3 7 24 3 7 24 (220 bp), c-fos (236 bp), c-mycr ~~~~~~~~~~~~~~~~~~~~(187bp), c-jun (325 bp), and
a5 + + + JUN-B (257 bp) after stan-dardization of cDNA levels
for actin message levels. (B)
Replicate samples of pSVneo
(aS-) and a 5-positivec-fos (a5+) transfectants were
cultured in suspension for
up to 24 h before isolation of
RNA at 3, 7, and 24 h after
c-mvc suspension initiation and
synthesis of first strand
cDNA as described in MA-
TERIALS AND METHODS. PCR analyses for expression of gene products was performed at 56°C using primers specific for c-fos (product
size of 236 bp) and c-myc (product size of 187 bp) after standardization of cDNA levels for actin message levels. Results of PCR analyses were
analyzed after electrophoresis on 2% TBE agarose gels and ethidium bromide-stained products were photographed.
effect different biological behaviors (Klemke et al.,
1994).
Unlike the parental HT29 cells or pSVneo transfec-
tants, the a5f31 transfectants were unable to form tu-
mors efficiently in nude mice. No evidence of fibronec-
tin expression or presence in any HT29 tumor was
observed, suggesting that the receptor is unoccupied
by fibronectin in the tumors (Varner and Juliano, un-
published results). Although colon carcinoma cells se-
crete many growth factors, including TGF-a, TGF-3,
PDGF (Anzano et al., 1989), and EGF, pSVneo and
a5/1 transfectants exhibited no differences in expres-
sion levels of these growth factors. Differences in tu-
mor formation thus cannot be attributed to intrinsic
growth factor differences nor to a deficiency in vascu-
larization because both a5p11-positive and control tu-
mors appeared to be equally well vascularized. The
a5f31 transfectants do not synthesize fibronectin in an
in vitro or in vivo setting and they lack the capacity to
organize fibronectin into a matrix (Varner and Juliano,
unpublished results).
An examination of the downstream molecular
mechanism by which this in vivo and in vitro inhibi-
tion of cellular proliferation occurs identified a series
of transcriptional events that are associated with
a5p11-dependent attachment to a fibronectin substrate.
The most striking of these transcriptional events is the
de novo transcription of gas-1 (del Sal et al., 1992, 1994)
by a5f31 transfectants when they are cultured in the
absence of attachment to fibronectin. Gas-1 is a 46-kDa
cell surface protein that is expressed de novo at the
borders of contact inhibited and serum-starved cells.
Ectopic expression of gas-1 induces growth arrest in
normal as well as transformed cells. In addition to
inducing the transcription of a growth arrest gene,
failure to ligate a513l is associated with reduced tran-
scription of the immediate early genes c-fos, c-jun, and
jun B, but not of c-myc. The immediate early genes
c-fos, c-jun, and jun B are transcribed in a burst of
transcriptional activity upon stimulation of growth-
arrested (adherent) normal cells with serum growth
factors (Rollins and Stiles, 1989; Rivera and Greenberg,
1990). They are required for the transition from GO to
Gi (Nishikura and Murray, 1987; Smith and
Prochownik, 1992) and hence for cellular proliferation
(Riabowol et al., 1988; Ryder and Nathans, 1988;
Ryseck et al., 1988; Herschman, 1991; Kovary and
Bravo, 1991). In contrast, the immediate early gene
c-myc is not required for the GO/Gi transition, but
plays a role in regulating the GI to S transition
(Heikkla et al., 1987). In fact, c-myc expression is
present at measurable levels through the cell cycle
(Evan et al., 1992). Hence, as observed for the HT29
transfectants and control cells, c-myc is generally reg-
ulated separately from the immediate early genes c-
fos, c-Jun, and jun B.
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Cellular adhesion has been associated with gene
expression of immediate early genes, proteases, and
cytokines in monocytes (Haskill et al., 1988, 1991;
Sporn et al., 1989), synovial fibroblasts (Werb et al.,
1989), and T cells (Yamada et al., 1991). When a5f31
transfected HT29 cells adhere to fibronectin, but not to
other substrates such as vitronectin, collagen, or
polyL-lysine, immediate early gene expression is in-
duced while gas-1 transcription is suppressed. After
adhesion to fibronectin, cells subsequently synthesize
DNA and proliferate at nearly the same rate as the
parental and pSVneo transfectant cell lines. These
transcription and proliferation events are not medi-
ated by mere cell attachment, as they are not induced






by cell attachment to and spreading on vitronectin,
collagen, or polyL-lysine. Although adhesion and in-
tegrin-clustering events have previously been shown
to induce intracellular events leading to de novo gene
expression, we have been able to demonstrate that
simple a5f31 expression versus a531-mediated cell ad-
hesion induces distinct patterns of gene expression.
Integrins generate intracellular signals in response
to clustering by adhesion or by antibodies, which in-
clude synthesis of phosphatidylinositol phosphate, ac-
tivation of protein kinase C, and tyrosine phosphory-
lation (for review, Juliano and Haskill, 1993). Integrin
cytoplasmic tails interact directly with some cytoskel-
etal (Otey et al., 1990) and signaling molecules (Otey et
B fibronectin
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Figure 9. Adhesion to fibronectin up-regulates immediate
early gene expression but down-regulates gas-1 expression. (A)
Replicate samples of pSVneo (a5-) and a5-positive (a5+) trans-
fectants were adhered to fibronectin-coated tissue culture plas-
tic for 0, 1, 2, 3, or 4 h after 12 h of suspension before isolation
of RNA and synthesis of first strand cDNA. PCR analyses of
expression of gene products was performed at 56'C using prim-
ers specific for histone H4 (347 bp), c-fos (236 bp), c-myc (187 bp),
and after standardization of cDNA levels for actin message
levels (150 bp). (B) Replicate samples of a5-positive transfec-
tants were adhered to fibronectin for 0 or 3 h after 12 h of
suspension before isolation of RNA and synthesis of first strand
cDNA. PCR analyses of expression of gene products was per-
formed at 56'C using primers specific for gas-1 (322 bp) after
standardization of cDNA levels for actin message levels (150
bp). (C) Replicate samples of a5-positive transfectants were
adhered to fibronectin or polyL-lysine for 0, 1, or 3 h after 12 h
of suspension before isolation of RNA and synthesis of first
strand cDNA. PCR analyses of expression of gene products
was performed at 56'C using primers specific for c-fos (236
bp) after standardization of cDNA levels for actin message
levels (150 bp). Results of all PCR amplifications were ana-
lyzed after electrophoresis on 2% TBE agarose gels and
ethidium bromide-stained products were photographed.
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al., 1993). Ligation-induced alterations in integrin con-
formation may stimulate a cascade of signaling events
that ultimately lead to transcription. ca5f31 exertion of
a dominant negative effect on proliferation in colon
carcinoma may indicate that the unligated integrin
a5,31 interacts directly with a key regulatory element
of a preexisting signaling cascade, thus inhibiting its
participation in signaling. Ligation by fibronectin may
permit release of this signaling molecule and hence
the cascade of events that lead to proliferation. It is
important to note that the gene expression changes
described here are not directly correlated with cell
spreading or with focal contact formation because
both a5-positive and -negative cells adhere to and
spread on vitronectin but their growth differential is
not altered. Hence, although both alterations in gene
expression and in cytoskeletal arrangement are
though to be the result of signal transduction events,
the gene transcription events we describe are dissoci-
ated from simple cell spreading due to the very dif-
ferent effects on proliferation displayed by different
matrices.
The integrin aS,1 has previously been implicated in
tumor suppression (Dedhar et al., 1987, 1989; Giancotti
and Ruoslahti, 1990; Symington, 1990, 1993). In each of
the previous experimental systems studied, overex-
pression of a531 by 5- to 30-fold was required to
suppress tumor growth. In the studies we describe
here, levels of a5,1 expression equivalent to those of
other HT29 cell surface integrins were sufficient to
suppress tumorigenicity and in vitro growth in the
absence of fibronectin. In each of these studies, failure
to ligate all of the tumor cell a51 molecules with
sufficient fibronectin may account for the in vivo tu-
mor suppression. We therefore suggest that the liga-
tion state of the integrin a51P is capable of regulating
the cell cycle by modulating a signaling pathway that
is required to induce immediate early gene expression
and suppression of the expression of the growth arrest
inducing gene, gas-1.
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